Literature DB >> 8983286

Rheumatoid arthritis and cancer risk.

L Mellemkjaer1, M S Linet, G Gridley, M Frisch, H Møller, J H Olsen.   

Abstract

The aim of this study was to examine the cancer pattern in a large group of patients with rheumatoid arthritis (RA). A follow-up study of cancer incidence in RA was conducted within a cohort of 20,699 patients recorded in the Danish Hospital Discharge Register during 1977-1987 by linkage with the Danish Cancer Registry through 1991. There were consistent excesses of non-Hodgkin's lymphoma and Hodgkin's disease in both sexes and during both early and late periods of follow-up. Risks for lung cancer and non-melanoma skin cancer were also increased, with no predilection for any specific histological subtype, while risks for colorectal cancer and female breast cancer were reduced. The cancer pattern seen among Danish RA patients largely supports findings from two earlier Nordic investigations. Thus, there seem to be consistent positive associations between RA and non-Hodgkin's lymphoma, Hodgkin's disease and lung cancer and a consistent negative association with colorectal cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8983286     DOI: 10.1016/0959-8049(96)00210-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  86 in total

Review 1.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

Review 2.  A question of transformation: the synovial fibroblast in rheumatoid arthritis.

Authors:  Laurie S Davis
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies.

Authors:  Anna K Wong; Susan Kerkoutian; Jonathan Said; Hooman Rashidi; Sheeja T Pullarkat
Journal:  Clin Rheumatol       Date:  2011-11-18       Impact factor: 2.980

Review 4.  Advances in targeted therapy: safety of biological agents.

Authors:  E C Keystone
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

5.  Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses' Health Study.

Authors:  Jeffrey A Sparks; Shun-Chiao Chang; Katherine P Liao; Bing Lu; Alexander R Fine; Daniel H Solomon; Karen H Costenbader; Elizabeth W Karlson
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-06       Impact factor: 4.794

6.  Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.

Authors:  T Mitterlechner; M Fiegl; H Mühlböck; W Oberaigner; S Dirnhofer; A Tzankov
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

7.  Infliximab-associated lymphoproliferative disorders.

Authors:  Yoshihiko Hoshida; Shigeo Yamamoto; Naoki Wada; Jing-Xian Xu; Toru Sasaki; Katsuyuki Aozasa
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

8.  Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis.

Authors:  Stefanos Bonovas; Kalitsa Filioussi; Nikolaos M Sitaras
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

9.  Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.

Authors:  M H Schiff; G R Burmester; J D Kent; A L Pangan; H Kupper; S B Fitzpatrick; C Donovan
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

10.  A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.

Authors:  Ruby Matsumoto; Kazushi Numata; Nobutaka Doba; Koji Hara; Makoto Chuma; Hiroyuki Fukuda; Akito Nozaki; Katsuaki Tanaka; Yoshimi Ishii; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2016-08-30       Impact factor: 1.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.